BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8181077)

  • 1. In vitro effects of solubilized HLA-DR--role in immunoregulation?
    Claus R; Hausmann S; Zavazava N; Walzel H; Schulze HA; Köhler H; Friemel H; Müller-Ruchholtz W
    Cell Immunol; 1994 May; 155(2):476-85. PubMed ID: 8181077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
    Moriya N; Sanjoh K; Yokoyama S; Hayashi T
    J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified HLA class II peptide complexes can induce adherence and activation of peptide-specific human T cell clones.
    van Schooten WC; Maiore T; Jones KR; Paborsky L
    J Immunol; 1992 Feb; 148(4):1043-8. PubMed ID: 1531349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
    Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
    Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
    Merkenschlager M; Altmann DM; Ikeda H
    J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse.
    Zhong M; Weng X; Liang Z; Lu S; Li J; Chen X; Li Q; Sun W; Song Y; Shen G; Wu X
    Transplantation; 2009 Jan; 87(1):8-15. PubMed ID: 19136885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
    Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
    Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLR-specific suppressor T lymphocytes in man. II. Functional and membrane characteristics of a specific MLR suppressor subpopulation.
    Fabio G; Scorza-Smeraldi R; Bonara P; Sabbadini Villa MG; Vanoli M; Calabi F; Zanussi C
    J Immunol; 1982 Dec; 129(6):2458-62. PubMed ID: 6216283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counter-antigen presentation: fibroblasts produce cytokines by signalling through HLA class II molecules without inducing T-cell proliferation.
    Ohyama H; Nishimura F; Meguro M; Takashiba S; Murayama Y; Matsushita S
    Cytokine; 2002 Feb; 17(4):175-81. PubMed ID: 11991669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
    Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
    J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional abolition of monocyte HLA-DR by aldehyde treatment. A novel approach to studies of class II restriction elements in antigen presentation.
    Rhodes J; Tite J
    J Immunol; 1988 May; 140(10):3344-51. PubMed ID: 3361123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
    Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
    Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific IgG autoantibodies are potent inhibitors of autoreactive T cell response to phytohemagglutinin-activated T cells.
    Wolf-Levin R; Azuma T; Aoki K; Yagami Y; Okada H
    J Immunol; 1993 Nov; 151(10):5864-77. PubMed ID: 8228265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactions.
    Engleman EG; Benike CJ; Charron DJ
    J Exp Med; 1980 Aug; 152(2 Pt 2):114s-126s. PubMed ID: 6447741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High precursor frequency of human T cells reactive to HLA-DQ molecules expressed on mouse L cell transfectants.
    Fujisawa K; Kamikawaji N; Yasunami M; Kimura A; Nishimura Y; Sasazuki T
    Eur J Immunol; 1991 Oct; 21(10):2341-7. PubMed ID: 1717282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy.
    Kriegel MA; Adam-Klages S; Gabler C; Blank N; Schiller M; Scheidig C; Kalden JR; Lorenz HM
    Int Immunol; 2008 Apr; 20(4):601-13. PubMed ID: 18310062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to Toxoplasma gondii--analysis of suppressor T cells in a patient with symptomatic acute toxoplasmosis.
    Yano A; Norose K; Yamashita K; Aosai F; Sugane K; Segawa K; Hayashi S
    J Parasitol; 1987 Oct; 73(5):954-61. PubMed ID: 2958613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High concentration of soluble HLA-DR in the synovial fluid: generation and significance in "rheumatoid-like" inflammatory joint diseases.
    Claus R; Bittorf T; Walzel H; Brock J; Uhde R; Meiske D; Schulz U; Hobusch D; Schumacher K; Witt M; Bartel F; Hausmann S
    Cell Immunol; 2000 Dec; 206(2):85-100. PubMed ID: 11161440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.